Publications by authors named "Adriana Scavuzzi"
Purpose: To evaluate the compliance and degree of satisfaction of nulligravida (has not given birth) and parous (had already given birth) women who are using intrauterine devices (IUDs).
Methods: A cross-sectional cohort study was conducted comparing nulligravida and parous women who had had an IUD inserted between July 2009 and November 2011. A total of 84 nulligravida women and 73 parous women were included.
Study Question: How effective is the vaginal administration of misoprostol in dilating the cervix prior to inserting an intrauterine device (IUD) in nulligravidas?
Summary Answer: The use of misoprostol at a dose of 400 µg administered vaginally 4 h prior to IUD insertion increased the ease of insertion and reduced the incidence of pain during the procedure, although the frequency of cramps increased following misoprostol use.
What Is Known And What This Paper Adds: Misoprostol has been widely used in Obstetrics and Gynecology; however, its usefulness and efficacy in facilitating IUD insertion in nulligravidas have yet to be established. The present study shows that the benefits of misoprostol use prior to IUD insertion include facilitating insertion and reducing pain during the procedure; therefore, weighing up the benefits encountered against the only negative side effect (cramps prior to insertion), these results suggest that misoprostol use should become standard practice to facilitate IUD insertion in nulligravidas.
Article Synopsis
- The study aimed to evaluate the safety and effectiveness of a new oral misoprostol formulation for inducing labor in term pregnancies.
- A pilot trial with 30 pregnant women showed that 96.7% successfully began labor, with an average time of 3.8 hours from the first dose to contractions.
- The results indicated high rates of vaginal delivery (80%) and acceptable safety outcomes, but the authors suggest more comprehensive trials comparing this oral method to traditional vaginal administration.
Study Objective: To compare results of diagnostic hysteroscopy in postmenopausal women using misoprostol for cervical ripening.
Design: A randomized, placebo-controlled clinical trial (Canadian Task Force classification Ib).
Setting: Hospital Barão de Lucena, Instituto Materno Infantil de Pernambuco.